Retinoblastoma Consolidation in Egyptians
ConditionRetinoblastoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAssiut University
About this trial
This analysis will evaluate the investigators' institution's specific experience using Ru-106 isotopes, cryotherapy, or transpupillary thermotherapy (TTT) to treat persistent or recurrent RB in patients who previously underwent systemic IVC or IAC. The investigators aim to detail the demographics, clinical indications, success rates-specifically local control and globe salvage-, predictive factors for success, and complications of each modality of treatment within a tertiary eye care setting in Egypt.
Eligibility criteria
Qualifiers
Patients receiving secondary consolidation therapy with at least one year of post-treatment follow-up.
Disqualifiers
Incomplete data, extraocular or orbital RB at initial presentation, or follow-up duration under one year.
Trial design
Treatments tested in this trial
- transpupillary thermotherapy
- Cryotherapy
- Brachytherapy
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov